ciplenza
- News
Cipla gets DCGI nod to sell Favipiravir under brand ‘Ciplenza’
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name…
- Health
Yusuf Hamied’s Cipla to launch Ciplenza for COVID treatment soon
New Delhi: Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients, according…
